ARCHIVES

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

This article is from The Cancer Letter archive.

Vol. 01 No. 20 | June 21, 1974

Download PDF Visit The Full Archive

Related Articles

Two-Month Survival Benefit For Some NSCLC Patients

May 31, 2002

New Treatment Approaches For A Variety Of Leukemias Described At ASH Meeting

January 30, 2004

ASCO Backs Sentinel Node Biopsy In Some Early Stage Breast Cancer

September 30, 2005

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

April 1, 2005

Combination Skin Treatments Reduce Rash From Vectibix

June 26, 2009